Drug intelligence / Profile preview

Xueping tablet

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Xueping tablet is a Traditional Chinese Medicine (TCM) preparation indicated for the treatment of abnormal uterine bleeding (AUB). It is administered orally in tablet form. Its therapeutic effects are attributed to its ability to clear heat, remove blood stasis, stop bleeding, and regularize menstruation. Mechanistically, Xueping tablet has been shown to inhibit the inflammatory response mediated by the VEGF-ERK1/2 pathway. This involves reducing the expression levels of various inflammatory factors and matrix metalloproteinases, such as VEGF, p-ERK, NF-κB, SAA, MMP-2, MMP-9, TIMP-1, TIMP-2, and TIMP-3, while also increasing progesterone levels. The drug is manufactured by Jiangxi Puzheng Pharmaceutical Co., Ltd.

Other names
血平片XPT
02

Targets

TIMP3 (Tissue inhibitor of metalloproteinases 3)TIMP1 (Metalloproteinase inhibitor 1)NF-κBMMP9 (Matrix metalloproteinase-9)VEGFA (Vascular endothelial growth factor A)MMP2 (Matrix metalloproteinase-2)TIMP2MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on Xueping tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xueping tablet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call